Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Morphine in Chest Trauma
NCT03580187Phase 3Completed
- Sponsor
- Tahar Sfar University Hospital
- Start
- Jun 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of morphine in blunt thoracic injury (BTI), sponsored by Tahar Sfar University Hospital. Primary endpoint: Visual Analog Scale for Pain at 30 minutes. Started Jun 2018; status: completed.
02
Drugs
morphine
03
Conditions
blunt thoracic injury (BTI)
Beyond the preview
Go deeper on NCT03580187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580187.